Delivery Order SPE2DE21D7010-SPE2D626F69M6
- Not listed
- Nuvasive, Inc., a San Diego-based medical device manufacturer and subsidiary of Transplant Technology Inc., was awarded a $34,087.06 delivery order (4570297341) by the Defense Logistics Agency Medical Supply Chain on December 15, 2025, for the supply of RELINE-ONE spinal implant products. The contract is structured as a fixed-price delivery order with economic price adjustment provisions and carries an ultimate completion date of December 16, 2025. This award was issued under open market...
- Nuvasive, Inc., a San Diego-based medical device manufacturer and subsidiary of Transplant Technology Inc., was awarded a fixed-price delivery order valued at $12,607.94 by the Defense Logistics Agency (DLA) Medical Supply Chain on December 12, 2025. This delivery order, with an ultimate completion date of January 5, 2026, covers the procurement of RELINE OPEN IMPLANTS—specialized spinal surgical implants designed to support advanced orthopedic and neurosurgical procedures. The award was...
- Nuvasive, Inc., a San Diego-based medical device manufacturer and subsidiary of Transplant Technology Inc., was awarded a $12,607.94 fixed-price delivery order (contract number 4570040417) by the Defense Logistics Agency Medical Supply Chain on November 13, 2025, for RELINE OPEN IMPLANTS to be delivered by December 5, 2025. The contract was awarded without set-aside designation through open market competition and includes an economic price adjustment mechanism to accommodate cost fluctuations....
- Nuvasive, Inc., a San Diego-based medical device manufacturer and subsidiary of Transplant Technology Inc., was awarded a $31,501.86 delivery order (Contract No. 4570253545) by the Defense Logistics Agency Medical Supply Chain on December 11, 2025, with an ultimate completion date of January 2, 2026. The contract, issued without set-aside designation, is structured as a fixed-price delivery order with economic price adjustment mechanisms and covers the RELINE-ONE spinal implant product line....
- Nuvasive, Inc., a San Diego-based medical device manufacturer and subsidiary of Transplant Technology Inc., was awarded a delivery order valued at $21,266.40 by the Defense Logistics Agency (DLA) Medical Supply Chain on December 10, 2025. This firm fixed-price delivery order with economic price adjustment mechanisms is scheduled for completion by December 31, 2025, and will be performed at Nuvasive's San Diego facility. The contract carries no set-aside designation, reflecting Nuvasive's...
- Nuvasive, Inc., a San Diego-based medical device manufacturer and subsidiary of Transplant Technology Inc., was awarded a delivery order valued at $55,910.77 on December 11, 2025, for reline open implants under contract 4570278357. This fixed-price delivery order with economic price adjustment mechanisms is funded through the Defense Logistics Agency Medical Supply Chain, which procures medical supplies and equipment for Department of Defense and Department of Veterans Affairs healthcare...
- Nuvasive, Inc., a San Diego-based medical device manufacturer and subsidiary of Transplant Technology Inc., was awarded a delivery order valued at $15,124.90 on November 12, 2025, for RELINE MAS IMPLANTS under contract number 4569992779. The contract utilizes fixed-price pricing with economic price adjustment mechanisms and carries an ultimate completion date of December 3, 2025. This delivery order was issued without set-aside designation through the Defense Logistics Agency Medical Supply...
- Nuvasive, Inc., a San Diego-based medical device manufacturer and subsidiary of Transplant Technology Inc., was awarded a delivery order on November 3, 2025, for RELINE MAS IMPLANTS with a ceiling value of $22,376.93 and an ultimate completion date of November 24, 2025. This fixed-price contract with economic price adjustment was issued without set-aside designation by the Defense Logistics Agency Medical Supply Chain, a component of the Department of Defense responsible for procuring medical...
- Nuvasive, Inc., a San Diego-based medical device manufacturer and subsidiary of Transplant Technology Inc., was awarded a delivery order valued at $4,682.23 on December 5, 2025, for RELINE MAS IMPLANTS through the Defense Logistics Agency (DLA) Medical Supply Chain. The contract is structured as a fixed-price delivery order with economic price adjustment provisions and carries an ultimate completion date of December 30, 2025. No set-aside designation was used in this competitive procurement....
- Nuvasive, Inc., a San Diego-based medical device manufacturer specializing in spinal surgery products and implants, has been awarded a $39,829.90 delivery order by the Defense Logistics Agency (DLA) Medical Supply Chain, a defense-focused federal agency. The contract, designated as RELINE-ONE, is structured as a fixed-price delivery order with economic price adjustment mechanisms and carries no set-aside designation, indicating open market competition. The place of performance is San Diego,...
- SPE2DE21D7010Indefinite Delivery Contract
- SPE2DE21D7010-SPE2D626F69M6Delivery Order
Nuvasive, Inc., a San Diego-based medical device manufacturer and subsidiary of Transplant Technology Inc., was awarded a $25,055.23 delivery order (Contract No. 4570398009) by the Defense Logistics Agency (DLA) Medical Supply Chain on December 23, 2025, with an ultimate completion date of January 22, 2026. The delivery order is for RELINE OPEN IMPLANTS, spinal surgical devices that support advanced orthopedic and neurosurgical procedures across Department of Defense and Department of Veterans Affairs healthcare facilities. The contract employs a fixed-price structure with economic price adjustment provisions, was awarded without set-aside designation in open market competition, and will be performed at Nuvasive's San Diego, California facility. This delivery order is issued under Nuvasive's broader $8 million Blanket Purchase Agreement (IDIQ vehicle) with the Defense Health Agency, effective through March 2027, which streamlines procurement and rapid ordering of Nuvasive's comprehensive portfolio of spinal fusion devices, implants, surgical instruments, and bone graft materials. The BPA framework enables military and veteran healthcare providers to efficiently access specialized spinal technologies required for advanced surgical missions, with delivery orders typically completed within weeks to months to meet the urgent medical supply needs of the federal healthcare system.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $25.1k | 12/22/25 |